HIGHLIGHTS
- who: Baocheng Gong from the Sapienza University of Rome Italy have published the Article: Corrigendum: Downregulation of ATXN3 enhances the sensitivity to AKT inhibitors (Perifosine or MK-2206), but decreases the sensitivity to chemotherapeutic drugs (etoposide or cisplatin) in neuroblastoma cells, in the Journal: (JOURNAL)
SUMMARY
Neuroblastoma, ataxin-3, BIM, Bcl-xl, perifosine, MK-2206, etoposide, cisplatin A corrigendum on Downregulation of ATXN3 enhances the sensitivity to AKT inhibitors (Perifosine or MK-2206), but decreases the sensitivity to chemotherapeutic drugs (etoposide or cisplatin) in neuroblastoma cells by Gong B, Zhang J, Hua Z . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.